Merck (LTS:0QAH) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0QAH Merck & Co Inc LTS:0QAH
79 GF Score
Price $131.23
GF Value $118.56
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Merck FFO per Share?

FFO per Share only applies to REITs.

LTS:0QAH
79GF Score
Merck & Co Inc LTS:0QAH
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (LTS:0QAH) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of $131.23 is trading 10.7% above its estimated GF Value™ of $118.56. GuruFocus considers Merck to be Modestly Overvalued.

Key valuation signals for LTS:0QAH:

  • FFO per Share:
  • GF Value™: $118.56 vs. price of $131.23 (10.7% above fair value)
  • GF Score™: 79/100 with 8 warning signs

No single metric tells the full story. See the LTS:0QAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
79GF Score

Get the complete analysis for LTS:0QAH

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$131.23
Price
$118.56
GF Value